Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency Cover

.blurhash-client-img { display: none !important; }

Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency

Endocrine Regulations

Volume 56 (2022): Issue 3 (July 2022)

By: Meriem Yazidi, Cyrine Danguir, Dhouha Maamer, Ibtissem Oueslati, Karima Khiari, Mohamed Elleuch, Moncef Feki and Melika Chihaoui

Open Access

|Jul 2022

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/enr-2022-0022 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 209 - 215

Published on: Jul 13, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

primary adrenal insufficiency,

bone mineral density,

bone turnover markers,

hydro-cortisone,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Meriem Yazidi, Cyrine Danguir, Dhouha Maamer, Ibtissem Oueslati, Karima Khiari, Mohamed Elleuch, Moncef Feki, Melika Chihaoui, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 3 (July 2022)Next article